Table 3.
No. | Survey questions | Personal | Practice | Proximity | Preparedness | Preferences | C | O | M | B | |
---|---|---|---|---|---|---|---|---|---|---|---|
Future practice | Education | ||||||||||
1 | What is your gender?a | ✖ | |||||||||
2 | What is your age bracket?a | ✖ | |||||||||
3 | Where are you located?a | ✖ | |||||||||
4 | Do you see patients in your practice?a | ✖ | |||||||||
5 | What is your current level of specialty certification?a | ✖ | |||||||||
6 | In what year did you complete your medical degree (MBBS/MD)?a | ✖ | |||||||||
7 | What medical specialty are you qualified for, accredited in or studying towards?a | ✖ | |||||||||
8 | Which categories of patients do you see?a | ✖ | |||||||||
9 | Who is your main employer?a | ✖ | |||||||||
10 | In the last 12 months, what was your main work location?a | ✖ | |||||||||
11 | Do clinical guidelines exist for genomic testing in your specialty?b | ✖ | ✖ | ✖ | ✖ | ✖ | |||||
12 | Have you been involved in any genomic research projects in the last 5 years?a | ✖ | ✖ | ✖ | ✖ | ✖ | ✖ | ||||
13 | Have you contacted your clinical genetics team or service in the last 12 months?c | ✖ | ✖ | ✖ | ✖ | ✖ | ✖ | ||||
14 | Did you order chromosomal microarray (microarray) tests in the last 12 months as part of your clinical or research role?d | ✖ | ✖ | ✖ | ✖ | ✖ | ✖ | ✖ | |||
15 | Did you order gene panel tests in the last 12 months as part of your clinical or research role?d | ✖ | ✖ | ✖ | ✖ | ✖ | ✖ | ✖ | |||
16 | Did you order whole exome or whole genome sequencing tests in the last 12 months as part of your clinical or research role?d | ✖ | ✖ | ✖ | ✖ | ✖ | ✖ | ✖ | |||
17 | Below is a list of some of the steps involved in genomic sequencing testing from pre-test to post-test. Please indicate which steps you currently perform and which ones you expect to perform in the future if you had adequate education, training and support.a | ✖ | ✖ | ✖ | ✖ | ✖ | |||||
18 | What is/would be your preferred model for delivering a genomic sequencing test in your clinical practice, assuming you have appropriate education, training and funding?d [Options for Inpatient vs Outpatient] | ✖ | ✖ | ✖ | ✖ | ||||||
19 | Below is a list of ways genomic sequencing tests and other genomic tests can be initiated and discussed with patients. Please indicate which currently occur in your practice and/or you believe will occur more frequently in the next five years.a,e | ✖ | ✖ | ✖ | ✖ | ||||||
20 | Do you think genomics will impact your practice in the next 2 years?b | ✖ | |||||||||
21 | Do you feel prepared to use genomic sequencing testing in your practice?b | ✖ | ✖ | ✖ | |||||||
22 | How confident are you in your: knowledge about genomics; ability to elicit information in a family or medical history; ability to explain concepts; ability to make decisions based on genomic information? What would help improve your confidence?f | ✖ | ✖ | ✖ | ✖ | ✖ | |||||
23 | Would improving your knowledge of genomic medicine alter your practice?e | ✖ | ✖ | ✖ | ✖ | ||||||
24 | Have you ATTENDED any professional development education or training around genomics in the past year, such as lectures, seminars or workshops, either in person or online?a | ✖ | ✖ | ✖ | ✖ | ||||||
25 | Have you PROVIDED any professional development education or training around genomics in the past year, such as lectures, seminars or workshops, either in person or online?a,c | ✖ | ✖ | ✖ | ✖ | ||||||
26 | Who should be responsible for updating medical specialists about genomics?e | ✖ | |||||||||
27 | Below is a list of activities that can be used to keep up to date with, or learn new skills in, genomic medicine. Please indicate which activities you currently use and/or would prefer to use to keep up to date with, or learn new skills in, genomic medicine.d | ✖ | ✖ | ✖ | ✖ | ||||||
28 | Below is a list of education topics in genomic medicine. Please indicate which topics you have learnt about and which you want to in the future.g | ✖ | ✖ | ✖ | ✖ |
Existing surveys were reviewed and relevant questions were selected (and modified in the Delphi rounds) for inclusion in the developed survey. Original sources were: a(Nisselle et al., 2019a); bCrafted by Australian Genomics Program 4 Working Group; cGECKO survey (Carroll et al., 2019); d(Stark et al., 2019b); e(Chow-White et al., 2017); f(Gray et al., 2014); g(Chen and Kim, 2014); C, capability; O, opportunity; M, motivation; B, behaviour (Michie et al., 2011).